Raymond James & Associates’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,952
| Closed | -$260K | – | 3551 |
|
|
2019
Q3 | $260K | Buy |
6,952
+829
| +14% | +$31K | ﹤0.01% | 3073 |
|
|
2019
Q2 | $267K | Buy |
6,123
+563
| +10% | +$24.6K | ﹤0.01% | 3056 |
|
|
2019
Q1 | $237K | Sell |
5,560
-946
| -15% | -$40.3K | ﹤0.01% | 3104 |
|
|
2018
Q4 | $291K | Sell |
6,506
-287
| -4% | -$12.8K | ﹤0.01% | 2881 |
|
|
2018
Q3 | $465K | Buy |
6,793
+551
| +9% | +$37.7K | ﹤0.01% | 2742 |
|
|
2018
Q2 | $357K | Buy |
6,242
+274
| +5% | +$15.7K | ﹤0.01% | 2898 |
|
|
2018
Q1 | $275K | Buy |
+5,968
| New | +$275K | ﹤0.01% | 2923 |
|
|
2017
Q4 | – | Sell |
-6,751
| Closed | -$304K | – | 3288 |
|
|
2017
Q3 | $304K | Sell |
6,751
-326
| -5% | -$14.7K | ﹤0.01% | 2769 |
|
|
2017
Q2 | $278K | Sell |
7,077
-188
| -3% | -$7.39K | ﹤0.01% | 2747 |
|
|
2017
Q1 | $277K | Sell |
7,265
-381
| -5% | -$14.5K | ﹤0.01% | 2726 |
|
|
2016
Q4 | $283K | Sell |
7,646
-5,445
| -42% | -$202K | ﹤0.01% | 2638 |
|
|
2016
Q3 | $454K | Buy |
13,091
+176
| +1% | +$6.1K | ﹤0.01% | 2347 |
|
|
2016
Q2 | $420K | Sell |
12,915
-3,155
| -20% | -$103K | ﹤0.01% | 2196 |
|
|
2016
Q1 | $462K | Buy |
+16,070
| New | +$462K | ﹤0.01% | 2082 |
|
|
2015
Q3 | – | Sell |
-11,822
| Closed | -$479K | – | 2261 |
|
|
2015
Q2 | $479K | Sell |
11,822
-26,648
| -69% | -$1.08M | ﹤0.01% | 2104 |
|
|
2015
Q1 | $1.89M | Buy |
38,470
+5,637
| +17% | +$277K | 0.01% | 1270 |
|
|
2014
Q4 | $1.49M | Buy |
+32,833
| New | +$1.49M | 0.01% | 1324 |
|